Repeat Fine Needle Aspiration Cytology (FNAC) in Thyroid Does Not Help in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS)

被引:1
作者
Ucak, Ramazan [1 ]
Turkyilmaz, Deniz [2 ]
Aygun, Nurcihan [3 ]
Kaya, Cemal [3 ]
Ozguven, Banu Yilmaz [1 ]
Kabukcuoglu, Fevziye [1 ]
Uludag, Mehmet [3 ]
机构
[1] Univ Hlth Sci, Sisli Hamidiye Etfal Hlth Applicat & Res Ctr, Dept Pathol, 19 May Dist,Etfal St, TR-34700 Istanbul, Turkey
[2] Univ Hlth Sci, Sisli Hamidiye Etfal Hlth Applicat & Res Ctr, Dept Radiol, Istanbul, Turkey
[3] Univ Hlth Sci, Sisli Hamidiye Etfal Hlth Applicat & Res Ctr, Dept Gen Surg, Istanbul, Turkey
关键词
Thyroid; Bethesda Category; AUS/FLUS; Repeat FNAC; BETHESDA CATEGORY III; MALIGNANCY RATE; NODULES; SYSTEM; ULTRASONOGRAPHY; MANAGEMENT; DIAGNOSIS;
D O I
10.1007/s12262-022-03515-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
Although the current recommendation in the category of "Atypia of undetermined significance/follicular lesion of undetermined significance" (AUS/FLUS) is a repetition of fine needle aspiration cytology (FNAC), it does not solve the problems. Our aim is to analyze the effectiveness of FNAC repeat in AUS/FLUS cases by comparing it with clinical and ultrasonographic criteria and to contribute to patient management. In our institution, 138 patients' results, of those who were operated with AUS/FLUS FNAC between 2014 and 2019 and who had definite pathological diagnoses with clinical-pathological-radiological data, were examined. We divided the AUS/FLUS cases in our center into those with and without repeat FNAC (rFNAC), and we evaluated those with definite pathological results of these nodules with all clinical radiological data. We found that the incidence of malignancy increased significantly as the nodule size increased (2.6 cm) and in the presence of microcalcification in all nodules whose initial biopsy result was AUS/FLUS (p = 0.047, p = 0.019, respectively). The malignancy rate was 19.8% (18/91 cases) in cases without rFNAC and 23.4% (11/47 cases) in nodules with rFNAC. The incidence of malignancy was found to be higher in patients with nodules of 2 cm and larger in rFNAC cases (p = 0.043), and in patients with solid and microcalcified nodules in cases without rFNAC, and the results were significant (p values 0.037 and 0.046, p < 0.05, respectively). It was remarkable that the incidence of malignancy increased with advanced age (57.5 +/- 14.2 years, p = 0.017) in rFNAC cases. No relationship was found between nodule size and advanced age in cases after rFNAC, and other clinical and radiological features other than the relationship between solid and microcalcified nodule and malignancy in cases without rFNAC. We found a significant correlation between a microcalcific and solid nodule larger than 2 cm and malignancy in elderly patients diagnosed with AUS/FLUS after the first biopsy. We recommend direct surgery without repeat FNAC in the management of cases with all of these criteria.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 21 条
  • [1] The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
    Allen, Laura
    Al Afif, Ayham
    Rigby, Matthew H.
    Bullock, Martin J.
    Trites, Jonathan
    Taylor, S. Mark
    Hart, Robert D.
    [J]. JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2019, 48 (1)
  • [2] The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look-backs to look-ahead
    Baloch, Zubair
    LiVolsi, Virginia A.
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (10) : 862 - 866
  • [3] The 2017 Bethesda System for Reporting Thyroid Cytopathology
    Cibas, Edmund S.
    Ali, Syed Z.
    [J]. THYROID, 2017, 27 (11) : 1341 - 1346
  • [4] Cibas ES., 2009, AM J CLIN PATHOL, V132, P658, DOI [10.1309/AJCPPHLWMI3JV4LA, DOI 10.1309/AJCPPHLWMI3JV4LA]
  • [5] Can Repeat Biopsies Change the Prognoses of AUS/FLUS Nodule?
    Evranos Ogmen, Berna
    Aydin, Cevdet
    Kilinc, Ibrahim
    Aksoy Altinboga, Aysegul
    Ersoy, Reyhan
    Cakir, Bekir
    [J]. EUROPEAN THYROID JOURNAL, 2020, 9 (02) : 92 - 98
  • [6] Ultrasound is helpful to differentiate Bethesda class III thyroid nodules A PRISMA-compliant systematic review and meta-analysis
    Gao, Lu-Ying
    Wang, Ying
    Jiang, Yu-Xin
    Yang, Xiao
    Liu, Ru-Yu
    Xi, Xue-Hua
    Zhu, Shen-Ling
    Zhao, Rui-Na
    Lai, Xing-Jian
    Zhang, Xiao-Yan
    Zhang, Bo
    [J]. MEDICINE, 2017, 96 (16)
  • [7] Repeated fine-needle aspiration cytology for the diagnosis and follow-up of thyroid nodules
    Graciano, Agnaldo Jose
    Chone, Carlos Takahiro
    Fischer, Carlos Augusto
    Bublitz, Giuliano Stefanello
    de Aquino Peixoto, Ana Jacinta
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2014, 80 (05) : 422 - 427
  • [8] Thyroid Fine-Needle Aspiration Reporting Rates and Outcomes Before and After Bethesda Implementation Within a Combined Academic and Community Hospital System
    Harvey, Aaron M.
    Mody, Dina R.
    Amrikachi, Mojgan
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (11) : 1664 - 1668
  • [9] 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
    Haugen, Bryan R.
    Alexander, Erik K.
    Bible, Keith C.
    Doherty, Gerard M.
    Mandel, Susan J.
    Nikiforov, Yuri E.
    Pacini, Furio
    Randolph, Gregory W.
    Sawka, Anna M.
    Schlumberger, Martin
    Schuff, Kathryn G.
    Sherman, Steven I.
    Sosa, Julie Ann
    Steward, David L.
    Tuttle, R. Michael
    Wartofsky, Leonard
    [J]. THYROID, 2016, 26 (01) : 1 - 133
  • [10] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
    Ho, Allen S.
    Sarti, Evan E.
    Jain, Kunal S.
    Wang, Hangjun
    Nixon, Iain J.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    Ghossein, Ronald
    Fish, Stephanie A.
    Wong, Richard J.
    Lin, Oscar
    Morris, Luc G. T.
    [J]. THYROID, 2014, 24 (05) : 832 - 839